"Ospedale privato no profit accreditato con il Sistema Sanitario Regionale"

During the past decade, Fondazione Poliambulanza - Istituto Ospedaliero conducted 64 clinical trials. In the 10-year time frame, 64 clinical trials started and 14 clinical trials were completed, i.e. on average, 21.9% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 9 clinical trials were completed. i.e. 27.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fondazione Poliambulanza - Istituto Ospedaliero" #1 sponsor was "Fondazione Poliambulanza Istituto Ospedaliero" with 12 trials, followed by "Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente" with 7 trials sponsored, "Mario Negri Institute for Pharmacological Research" with 5 trials sponsored, "Celgene" with 3 trials sponsored and "Pfizer" with 3 trials sponsored. Other sponsors include 46 different institutions and companies that sponsored additional 45 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fondazione Poliambulanza - Istituto Ospedaliero" #1 collaborator was "Fondazione Policlinico Universitario Agostino Gemelli IRCCS" with 4 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 3 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator, "The Queen Elizabeth Hospital" with 3 trials as a collaborator and "University Hospital Southampton NHS Foundation Trust" with 3 trials as a collaborator. Other collaborators include 125 different institutions and companies that were collaborators in the rest 118 trials.

According to Clinical.Site data, the most researched conditions in "Fondazione Poliambulanza - Istituto Ospedaliero" are "Respiratory Distress Syndrome" (4 trials), "Ulcerative Colitis" (4 trials), "Atrial Fibrillation" (3 trials), "Coronary Artery Disease" (3 trials) and "Crohn Disease" (3 trials). Many other conditions were trialed in "Fondazione Poliambulanza - Istituto Ospedaliero" in a lesser frequency.

Most popular intervention types in "Fondazione Poliambulanza - Istituto Ospedaliero" are "Drug" (40 trials), "Device" (16 trials), "Procedure" (13 trials), "Other" (8 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Carboplatin" (4 trials), "Cetuximab" (3 trials), "Gemcitabine" (3 trials) and "Ozanimod" (3 trials). Other intervention names were less common.

The vast majority of trials in "Fondazione Poliambulanza - Istituto Ospedaliero" are 74 trials for "All" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "Fondazione Poliambulanza - Istituto Ospedaliero". 2 are not yet recruiting, 19 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 39 completed trials in Fondazione Poliambulanza - Istituto Ospedaliero, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Fondazione Poliambulanza - Istituto Ospedaliero, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 20 trials that are defined as “Not Applicable".

Fondazione Poliambulanza - Istituto Ospedaliero has several departments that took part in Clinical trials: "Istituto Ospedaliero Fondazione Poliambulanza Di Brescia - Brescia (Bs) Oncologia Medica" - 4 trials, "Istituto Osped. Fondazione Poliambulanza - Unita' Operativa Di Cardiologia" - 3 trials, "Unità epatologica ed ecografia internistica a valenza dipartimentale, Fondazione Ospedaliera Poliambulanza" - 2 trials